rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    SCYX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      SCYNEXIS at guggenheim healthcare conference: dual-pipeline push
      Nov 9Investing.comSCYX
      Scynexis Inc earnings missed by $0.10, revenue fell short of estimates
      Nov 5Investing.comSCYX
      Scynexis: Q3 Earnings Snapshot
      Nov 5Yahoo FinanceSCYX
      SCYNEXIS reports phase 1 results for IV antifungal SCY-247
      Oct 22Investing.comSCYX
      SCYNEXIS Completes Phase 1 Study of Intravenous SCY-247, a Novel, Triterpenoid Antifungal in Development for Treatment and Prevention of Invasive Fungal Diseases
      Oct 22Yahoo FinanceSCYX
      SCYNEXIS completes phase 1 study of SCY-770 for kidney disease
      Oct 6Investing.comSCYX
      Scynexis stock surges on $214M BARDA contract for SCY-247
      Sep 28Yahoo FinanceSCYX
      SCYNEXIS secures BARDA contract for antifungal development
      Sep 28Investing.comSCYX
      Scynexis Shares Rise 13.9% After BARDA Awards SCY-247 Development Contract
      Sep 28Yahoo FinanceSCYX
      Why is Scynexis stock surging today?
      Sep 28Investing.comSCYX
      Scynexis appoints Steven Burke to board of directors
      Sep 22Investing.comSCYX
      Scynexis appoints Todd Minga as senior VP of R&D
      Sep 15Investing.comSCYX
      SCYNEXIS at Cantor healthcare conference: rare-disease push takes shape
      Sep 11Investing.comSCYX
      SCYNEXIS appoints new CFO amid leadership transition

      Detailed price information for Scynexis Inc (SCYX-Q) from The Globe and Mail including charting and trades.

      Sep 11The Globe and MailSCYX
      Scynexis names Sanjay Subramanian as chief financial officer
      Sep 10Investing.comSCYX
      SCYNEXIS Names Sanjay Subramanian as CFO
      Sep 10Yahoo FinanceSCYX
      12 Health Care Stocks Moving In Wednesday's Intraday Session
      Aug 26BenzingaSCYXBHVN
      SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

      JERSEY CITY, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX), a clinical-stage biotechnology company focused on developing innovative therapies for severe and difficult-to-treat diseases with significant unmet medical need, today announced the grant of an inducement equity award to a new Senior Director, with a grant date of August 24, 2026. The award was granted in connection with the commencement of the Senior Director’s employment with the Company, as a material induceme

      Aug 25Yahoo FinanceSCYX

      This is the newest page. Registered accounts read further back.